全文获取类型
收费全文 | 7424篇 |
免费 | 257篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 86篇 |
儿科学 | 179篇 |
妇产科学 | 67篇 |
基础医学 | 915篇 |
口腔科学 | 246篇 |
临床医学 | 449篇 |
内科学 | 1760篇 |
皮肤病学 | 123篇 |
神经病学 | 536篇 |
特种医学 | 363篇 |
外科学 | 1382篇 |
综合类 | 26篇 |
预防医学 | 134篇 |
眼科学 | 111篇 |
药学 | 392篇 |
中国医学 | 14篇 |
肿瘤学 | 928篇 |
出版年
2023年 | 34篇 |
2022年 | 66篇 |
2021年 | 108篇 |
2020年 | 64篇 |
2019年 | 99篇 |
2018年 | 128篇 |
2017年 | 125篇 |
2016年 | 142篇 |
2015年 | 139篇 |
2014年 | 198篇 |
2013年 | 255篇 |
2012年 | 406篇 |
2011年 | 468篇 |
2010年 | 272篇 |
2009年 | 286篇 |
2008年 | 458篇 |
2007年 | 493篇 |
2006年 | 475篇 |
2005年 | 470篇 |
2004年 | 500篇 |
2003年 | 458篇 |
2002年 | 455篇 |
2001年 | 63篇 |
2000年 | 63篇 |
1999年 | 109篇 |
1998年 | 126篇 |
1997年 | 130篇 |
1996年 | 128篇 |
1995年 | 93篇 |
1994年 | 96篇 |
1993年 | 102篇 |
1992年 | 46篇 |
1991年 | 53篇 |
1990年 | 48篇 |
1989年 | 42篇 |
1988年 | 41篇 |
1987年 | 36篇 |
1986年 | 40篇 |
1985年 | 33篇 |
1984年 | 41篇 |
1983年 | 36篇 |
1982年 | 36篇 |
1981年 | 35篇 |
1980年 | 23篇 |
1979年 | 16篇 |
1978年 | 28篇 |
1977年 | 15篇 |
1976年 | 16篇 |
1974年 | 12篇 |
1973年 | 14篇 |
排序方式: 共有7711条查询结果,搜索用时 15 毫秒
41.
Toshihiko Yusa Yoichi Yamashita Hirohisa Okabe Yosuke Nakao Rumi Itoyama Yuki Kitano Takayoshi Kaida Tatsunori Miyata Kosuke Mima Katsunori Imai Hiromitsu Hayashi Hideo Baba 《Cancer science》2022,113(12):4048
Inflammatory and immune cells in the tumor microenvironment are reported to be associated with tumor progression in several cancers. In total, 225 patients who underwent initial and curative hepatectomy for hepatocellular carcinoma (HCC) from 2004 to 2013 were enrolled in this study. Tumor‐associated neutrophils (TANs), M2 macrophages (TAMs; tumor‐associated macrophages), CD8+ T cells, and regulatory T cells (Tregs) were evaluated by immunohistochemistry (IHC), and their relationships with patient clinicopathological characteristics and prognosis were evaluated. IHC was performed focusing on TANs first. We could not find a relationship between intratumoral and peritumoral TANs and clinicopathological features except for the fibrous capsule and infiltration of tumors into capsule. Next, TAMs, CD8+ cells and Tregs were evaluated by IHC. At the peritumoral area, TANs and TAMs (r = 0.36, p = 0.001) or Tregs (r = 0.16, p = 0.008) showed a positive correlation, whereas TANs and CD8+ cells showed a negative correlation (r = −0.16, p = 0.02). As for survival outcomes, at the peritumoral area, high TANs (p = 0.0398), low CD8+ cells (p = 0.0275), and high TAMs (p = 0.001) were significantly associated with worse overall survival (OS). In addition, high TANs (p = 0.010), and high TAMs (p = 0.00125) were significantly associated with worse disease‐free survival (DFS). Finally, we established a risk signature model by combining the expression patterns of these cells. The high‐risk signature group had significantly worse OS (p = 0.0277) and DFS (p = 0.0219) compared with those in the low‐risk signature group. Our risk signature based on immune cells at the peritumoral area of the HCC can predict patient prognosis of HCC after curative hepatectomy. 相似文献
42.
43.
Efficacy of Trabectedin in Patients with Advanced Translocation‐Related Sarcomas: Pooled Analysis of Two Phase II Studies
下载免费PDF全文
![点击此处可从《The oncologist》网站下载免费的PDF全文](/ch/ext_images/free.gif)
44.
Identification of transforming activity of free fatty acid receptor 2 by retroviral expression screening 总被引:1,自引:0,他引:1
Hisashi Hatanaka Mamiko Tsukui Shuji Takada Kentaro Kurashina Young Lim Choi Manabu Soda Yoshihiro Yamashita Hidenori Haruta Toru Hamada Toshihide Ueno Kiichi Tamada Yoshinori Hosoya Naohiro Sata Yoshikazu Yasuda Hideo Nagai Kentaro Sugano Hiroyuki Mano 《Cancer science》2010,101(1):54-59
Gallbladder cancer (GBC) is a highly fatal malignancy in humans. Genetic alterations in KRAS or TP53 as well as overexpression of ERBB2 have been shown to contribute to the development of certain types of GBC. However, many cases of GBC do not harbor such genetic changes, with other transforming events awaiting discovery. We here tried to identify novel cancer-promoting genes in GBC, with the use of a retroviral cDNA expression library. A retroviral cDNA expression library was constructed from a surgically resected clinical specimen of GBC, and was used to infect 3T3 fibroblasts in a focus formation assay. cDNA incorporated into the transformed foci was rescued by PCR. One such cDNA was found to encode free fatty acid receptor 2 (FFAR2), a G protein-coupled receptor for short-chain fatty acids. The oncogenic potential of FFAR2 was confirmed both in vitro with the focus formation assay and by evaluation of cell growth in soft agar as well as in vivo with a tumorigenicity assay in nude mice. The isolated FFAR2 cDNA had no sequence alterations, suggesting that upregulation of FFAR2 expression may contribute to malignant transformation. Indeed, all of quantitative RT-PCR, in situ hybridization, and immunohistochemical analyses showed that the amount of FFAR2 mRNA and its protein product was increased in digestive tract cancer specimens. Furthermore, short-chain fatty acids potentiated the mitogenic action of FFAR2 in 3T3 cells. Our data thus, for the first time, implicate FFAR2 in carcinogenesis of the digestive tract. ( Cancer Sci 2009) 相似文献
45.
46.
47.
Daisuke Hiramatsu Yoshito Ogihara Takeshi Matsumoto Kei Sato Akihiro Takasaki Tairo Kurita Ryuji Okamoto Hideo Wada Kaoru Dohi 《Internal medicine (Tokyo, Japan)》2022,61(3):361
Congenital afibrinogenemia is a rare autosomal recessive blood disorder that accompanies thrombotic complications and is associated with bleeding tendency. The management of these opposing complications remains a challenge. Endovascular treatment (EVT) for peripheral arterial thrombosis has not been described in previous studies. A 57-year-old man with congenital afibrinogenemia developed back pain and left lower leg pain. The cause of the pain was confirmed to be renal infarction and lower extremity arterial thrombosis by Doppler ultrasound and contrast-enhanced computed tomography. He was treated with EVT for the lower extremity arterial thrombosis, leading to an excellent short-term improvement without bleeding. 相似文献
48.
Komuro Hideo 《Journal of cancer research and clinical oncology》1929,28(1):371-373
Ohne ZusammenfassungMit 2 Textabbildungen.Siehe Gann (jap.), Nipponische Z. Krebsforschg18, 322–324 (1924); Z. Krebsforschg22, 207–208 (1925).Der Kaiserlichen AkademieTeikoku Gakusiin möchte ich auch an dieser Stelle für die Bereitstellung der für die vorliegenden Untersuchungen erforderlichen Mittel meinen ergebensten Dank aussprechen. 相似文献
49.
50.